TECH

50.85

1.20% -0.62

Handel nachbörslich: 50.83 -0.02 -0.04%

Bio Techne Corp (TECH)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$51.47

Offen:

$52.27

24-Stunden-Volumen:

2.44M

Relative Volume:

1.08

Marktkapitalisierung:

$7.96B

Einnahmen:

$1.22B

Nettoeinkommen (Verlust:

$77.95M

KGV:

103.95

EPS:

0.4892

Netto-Cashflow:

$224.06M

1W Leistung:

-5.64%

1M Leistung:

-15.15%

6M Leistung:

-0.80%

1J Leistung:

-15.08%

1-Tages-Spanne:

$50.62

$52.58

1-Wochen-Bereich:

$49.86

$55.13

52-Wochen-Spanne:

$46.01

$72.16

Bio Techne Corp Stock (TECH) Company Profile

Firmenname

Bio Techne Corp

Sektor

Healthcare (1116)

Branche

Biotechnology (621)

Telefon

612-379-8854

Adresse

614 MCKINLEY PL N E, MINNEAPOLIS, MN

Mitarbeiter

3,100

Twitter

@biotechne

Nächster Verdiensttermin

2024-10-30

Neueste SEC-Einreichungen

TECH's Discussions on Twitter

Compare TECH vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TECH Bio Techne Corp	50.85	8.05B	1.22B	77.95M	224.06M	0.4892
VRTX Vertex Pharmaceuticals Inc	469.34	121.46B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	745.77	78.93B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	700.45	43.87B	4.16B	1.29B	734.26M	19.59
ALNY Alnylam Pharmaceuticals Inc	313.41	42.07B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	284.05	31.65B	5.36B	287.73M	924.18M	2.5229

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-09-03	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2025-08-21	Hochstufung	Citigroup	Neutral → Buy
2025-07-22	Fortgesetzt	Stephens	Overweight
2025-07-09	Eingeleitet	TD Cowen	Buy
2025-05-30	Eingeleitet	Wells Fargo	Overweight
2025-04-09	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2025-03-18	Eingeleitet	Evercore ISI	Outperform
2025-02-19	Herabstufung	Robert W. Baird	Outperform → Neutral
2024-05-22	Herabstufung	Citigroup	Buy → Neutral
2024-02-08	Eingeleitet	Scotiabank	Sector Outperform
2024-02-02	Herabstufung	Stifel	Buy → Hold
2023-12-07	Eingeleitet	UBS	Buy
2023-08-28	Eingeleitet	William Blair	Outperform
2023-01-10	Hochstufung	Wells Fargo	Underweight → Equal Weight
2022-12-14	Eingeleitet	Deutsche Bank	Buy
2022-12-12	Hochstufung	Citigroup	Neutral → Buy
2022-12-07	Eingeleitet	RBC Capital Mkts	Sector Perform
2022-08-25	Eingeleitet	Credit Suisse	Outperform
2022-04-25	Herabstufung	Wells Fargo	Equal Weight → Underweight
2021-09-15	Hochstufung	KeyBanc Capital Markets	Sector Weight → Overweight
2021-03-08	Hochstufung	Stephens	Equal-Weight → Overweight
2021-02-23	Hochstufung	Stifel	Hold → Buy
2021-01-25	Bestätigt	The Benchmark Company	Buy
2020-11-10	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2020-09-30	Eingeleitet	Atlantic Equities	Overweight
2020-07-15	Herabstufung	Stephens	Overweight → Equal-Weight
2020-05-27	Herabstufung	Stifel	Buy → Hold
2020-05-14	Eingeleitet	The Benchmark Company	Buy
2020-01-08	Fortgesetzt	Stephens	Overweight
2020-01-08	Eingeleitet	Wells Fargo	Equal Weight
2020-01-07	Eingeleitet	Citigroup	Neutral
2019-11-15	Eingeleitet	Stifel	Buy
2019-07-02	Hochstufung	Janney	Neutral → Buy
2019-01-14	Hochstufung	Stephens	Equal-Weight → Overweight
2018-10-31	Herabstufung	Craig Hallum	Buy → Hold
2018-10-17	Eingeleitet	Goldman	Neutral
2018-06-15	Eingeleitet	Argus	Buy
2017-07-13	Eingeleitet	Wells Fargo	Market Perform
2017-02-09	Eingeleitet	Citigroup	Buy
2017-01-18	Eingeleitet	Deutsche Bank	Buy
2016-11-10	Fortgesetzt	Leerink Partners	Outperform
2015-01-21	Bestätigt	Robert W. Baird	Outperform
2013-09-20	Hochstufung	Robert W. Baird	Neutral → Outperform

Alle ansehen

Bio Techne Corp Aktie (TECH) Neueste Nachrichten

03:09 AM

Is Bio-Techne Stock a Buy, Sell, or Hold After a Wealth Manager Dumps Its Entire Stake? - Yahoo Finance

03:09 AM

10:38 AM

Meridiem Capital Partners LP Makes New Investment in Bio-Techne Corp $TECH - MarketBeat

10:38 AM

Mar 12, 2026

April McClain Delaney makes multiple stock transactions in Bio-Techne, BJ’s Wholesale, and C.H Robinson - Investing.com Australia

Mar 12, 2026

Argus raises Bio-Techne stock price target on AI drug discovery tools - Investing.com Nigeria

Mar 12, 2026

Mackenzie Financial Corp Sells 59,511 Shares of Bio-Techne Corp $TECH - MarketBeat

Mar 12, 2026

Capital Research Global Investors Grows Stock Position in Bio-Techne Corp $TECH - MarketBeat

Mar 12, 2026

Rep. April McClain Delaney Sells Bio-Techne Corp Shares - National Today

Mar 12, 2026

Rep. April McClain Delaney Sells Bio-Techne Corp (NASDAQ:TECH) Shares - MarketBeat

Mar 12, 2026

Mar 11, 2026

CEO Moves: How does Bio Techne Corporation perform in inflationary periods2026 Technicals & Technical Entry and Exit Tips - baoquankhu1.vn

Mar 11, 2026

WINTON GROUP Ltd Sells 69,994 Shares of Bio-Techne Corp $TECH - MarketBeat

Mar 11, 2026

Jefferies Financial Group Invests $2.43M in Bio-Techne Corp - National Today

Mar 11, 2026

Jefferies Financial Group Inc. Makes New $2.43 Million Investment in Bio-Techne Corp $TECH - MarketBeat

Mar 11, 2026

31,091 Shares in Bio-Techne Corp $TECH Bought by B. Metzler seel. Sohn & Co. AG - MarketBeat

Mar 11, 2026

Mar 10, 2026

Bio-Techne at Leerink Global Healthcare Conference: Strategic Growth Insights - Investing.com India

Mar 10, 2026

Blair William & Co. IL Boosts Bio-Techne Corp Stake - National Today

Mar 10, 2026

Blair William & Co. IL Acquires 51,223 Shares of Bio-Techne Corp $TECH - MarketBeat

Mar 10, 2026

Mar 09, 2026

Is Bio-Techne (TECH) Now More a Macro Sentiment Story Than a Healthcare Innovation Play? - simplywall.st

Mar 09, 2026

Mar 08, 2026

Assessing Bio‑Techne (TECH) Valuation After Macro Jitters Hit Healthcare Stocks - simplywall.st

Mar 08, 2026

Mar 07, 2026

Neuberger Berman Group LLC Has $183.98 Million Stock Holdings in Bio-Techne Corp $TECH - MarketBeat

Mar 07, 2026

Mar 06, 2026

Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know - Yahoo Finance

Mar 06, 2026

Aug Big Picture: Will Bio Techne Corporation be affected by tariffsQuarterly Investment Review & AI Based Buy and Sell Signals - baoquankhu1.vn

Mar 05, 2026

Snyder Capital Management L P Has $95.64 Million Stake in Bio-Techne Corp $TECH - MarketBeat

Mar 05, 2026

Mar 04, 2026

TECH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 04, 2026

TD Asset Management Inc Acquires 36,424 Shares of Bio-Techne Corp $TECH - MarketBeat

Mar 04, 2026

Cresset Asset Management Boosts Stake in Bio-Techne - National Today

Mar 04, 2026

Cresset Asset Management LLC Increases Position in Bio-Techne Corp $TECH - MarketBeat

Mar 04, 2026

Mar 03, 2026

Bio-Techne Corp. stock outperforms competitors despite losses on the day - MarketWatch

Mar 03, 2026

Bio-Techne at TD Cowen Conference: Strategic Growth and Challenges - Investing.com

Mar 03, 2026

TECH Technical Analysis & ETF Price Forecast - Intellectia AI

Mar 03, 2026

Segall Bryant & Hamill LLC Sells 34,680 Shares of Bio-Techne Corp $TECH - MarketBeat

Mar 03, 2026

Champlain Investment Partners LLC Sells 963,441 Shares of Bio-Techne Corp $TECH - MarketBeat

Mar 03, 2026

American Century Companies Inc. Boosts Bio-Techne Stake - National Today

Mar 03, 2026

American Century Companies Inc. Grows Stock Position in Bio-Techne Corp $TECH - MarketBeat

Mar 03, 2026

3 Reasons to Avoid TECH and 1 Stock to Buy Instead - Finviz

Mar 03, 2026

Citigroup Trims Stake in Bio-Techne Corp - National Today

Mar 03, 2026

Mar 02, 2026

Bio-Techne Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Mar 02, 2026

Bio-Techne Corp. stock underperforms Monday when compared to competitors - MarketWatch

Mar 02, 2026

Royce & Associates Cuts Stake in Bio-Techne Corp - National Today

Mar 02, 2026